171 related articles for article (PubMed ID: 14967177)
1. Charge variants in serum and urine hCG.
Sutton JM
Clin Chim Acta; 2004 Mar; 341(1-2):199-203. PubMed ID: 14967177
[TBL] [Abstract][Full Text] [Related]
2. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
Cole LA; Butler S
J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
[TBL] [Abstract][Full Text] [Related]
3. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.
Cole LA; Kohorn EI; Kim GS
J Reprod Med; 1994 Mar; 39(3):193-200. PubMed ID: 8035374
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of two immunoassays for the measurement of human chorionic gonadotropin in urine for anti-doping purposes.
Robinson N; Sottas PE; Saugy M
Clin Lab; 2010; 56(5-6):197-206. PubMed ID: 20575467
[TBL] [Abstract][Full Text] [Related]
5. The analytical specificity of human chorionic gonadotropin assays determined using WHO International Reference Reagents.
Whittington J; Fantz CR; Gronowski AM; McCudden C; Mullins R; Sokoll L; Wiley C; Wilson A; Grenache DG
Clin Chim Acta; 2010 Jan; 411(1-2):81-5. PubMed ID: 19843470
[TBL] [Abstract][Full Text] [Related]
6. The need for a quantitative urine hCG assay.
Cole LA; Khanlian SA
Clin Biochem; 2009 May; 42(7-8):676-83. PubMed ID: 19026624
[TBL] [Abstract][Full Text] [Related]
7. Quantification of urinary chorionic gonadotropin in spontaneous abortion of pre-clinically recognized pregnancy: method development and analytical validation.
Reis MF; Aniceto P; Aguiar P; Simão F; Segurado S
Int J Hyg Environ Health; 2007 May; 210(3-4):419-27. PubMed ID: 17336148
[TBL] [Abstract][Full Text] [Related]
8. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
Spencer K
Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycosylated HCG expression in pregnancy: cellular origin and clinical applications.
Kovalevskaya G; Kakuma T; Schlatterer J; O'Connor JF
Mol Cell Endocrinol; 2007 Jan; 260-262():237-43. PubMed ID: 17092638
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 2 commercially available human chorionic gonadotropin immunoassays used in the management of gestational trophoblastic neoplasia.
Matsui H; Kihara M; Usui H; Tate S; Mitsuhashi A; Shozu M
J Reprod Med; 2009 Oct; 54(10):631-5. PubMed ID: 20677483
[TBL] [Abstract][Full Text] [Related]
11. Sialic acid-deficient invasive trophoblast antigen (sd-ITA): a new urinary variant for gestational Down syndrome screening.
Sutton JM; Cole LA
Prenat Diagn; 2004 Mar; 24(3):194-7. PubMed ID: 15057952
[TBL] [Abstract][Full Text] [Related]
12. Phantom hCG and phantom choriocarcinoma.
Cole LA
Gynecol Oncol; 1998 Nov; 71(2):325-9. PubMed ID: 9826481
[TBL] [Abstract][Full Text] [Related]
13. Effects of recombinant human LH and hCG on serum and urine LH and androgens in men.
Handelsman DJ; Goebel C; Idan A; Jimenez M; Trout G; Kazlauskas R
Clin Endocrinol (Oxf); 2009 Sep; 71(3):417-28. PubMed ID: 19170708
[TBL] [Abstract][Full Text] [Related]
14. A single serum test for measuring early pregnancy outcome with high predictive value.
Sutton-Riley JM; Khanlian SA; Byrn FW; Cole LA
Clin Biochem; 2006 Jul; 39(7):682-7. PubMed ID: 16765931
[TBL] [Abstract][Full Text] [Related]
15. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
Cole LA; Sutton JM
J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
[TBL] [Abstract][Full Text] [Related]
16. Between-method variation in human chorionic gonadotropin test results.
Cole LA; Sutton JM; Higgins TN; Cembrowski GS
Clin Chem; 2004 May; 50(5):874-82. PubMed ID: 15016725
[TBL] [Abstract][Full Text] [Related]
17. Human chorionic gonadotropin and associated molecules.
Cole LA
Expert Rev Mol Diagn; 2009 Jan; 9(1):51-73. PubMed ID: 19099349
[TBL] [Abstract][Full Text] [Related]
18. Exploring the complementary selectivity of immunocapture and MS detection for the differentiation between hCG isoforms in clinically relevant samples.
Lund H; Torsetnes SB; Paus E; Nustad K; Reubsaet L; Halvorsen TG
J Proteome Res; 2009 Nov; 8(11):5241-52. PubMed ID: 19719329
[TBL] [Abstract][Full Text] [Related]
19. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy.
Cervinski MA; Lockwood CM; Ferguson AM; Odem RR; Stenman UH; Alfthan H; Grenache DG; Gronowski AM
Clin Chim Acta; 2009 Aug; 406(1-2):81-5. PubMed ID: 19477170
[TBL] [Abstract][Full Text] [Related]
20. Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin.
Sturgeon CM; Berger P; Bidart JM; Birken S; Burns C; Norman RJ; Stenman UH;
Clin Chem; 2009 Aug; 55(8):1484-91. PubMed ID: 19541864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
